Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
July 29, 2013 -- InSightec Ltd, an Israeli medical device maker, reported that its ExAblate System was approved for China marketing by the CFDA. ExAblate is a focused ultrasound device combined with continuous MRI imaging that is used to treat uterine fibroids non-invasively. GE Healthcare is majority owner of InSightec and contributed 90% of its $31 million C funding last year. More details....
Stock Symbol: (NYSE: GE)
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
July 29, 2013 -- InSightec Ltd, an Israeli medical device maker, reported that its ExAblate System was approved for China marketing by the CFDA. ExAblate is a focused ultrasound device combined with continuous MRI imaging that is used to treat uterine fibroids non-invasively. GE Healthcare is majority owner of InSightec and contributed 90% of its $31 million C funding last year. More details....
Stock Symbol: (NYSE: GE)
Help employers find you! Check out all the jobs and post your resume.
